On November 11, 2024, the 2024 Hong Kong Listed Company Development Summit Forum and the 11th 「Top 100 Hong Kong Stocks」 Awards Ceremony were held in Hong Kong. The United Laboratories International Holdings Limited (3933.HK), with its remarkable achievements in the pharmaceutical industry and strong investment potential, was listed in four major categories: 「Top 50 Mid-Cap Enterprises」, 「Most Valuable Investment Award」, 「Top 25 Pharmaceutical Companies」, and 「Top 50 Hong Kong Stocks」, fully demonstrating its prominent position and growth potential in the Hong Kong capital market.